Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04205955 · ClinicalTrials.gov registry record · Phase 2

Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors

A Phase 2 study, sponsored by SWOG Cancer Research Network.

Completed
Registry status
Phase 2
Development phase
95
Enrollment target

NCT04205955 is a Phase 2 study that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 95 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04205955, a Phase 2 study, has completed, sponsored by SWOG Cancer Research Network.

COMPLETED
Registry status
Phase 2
Development phase
95 participants
Enrollment target

Study Summary

This phase II trial studies how a diet intervention works in improving bowel dysfunction symptoms related in colon or rectal cancer survivors. Changing a diet may be helpful in reducing the severity of bowel symptoms, including diarrhea and constipation, and improve quality of life in colon or rectal cancer survivors and help doctors learn how to help patients better in the future.

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Questionnaire Administration
  • OTHER Best Practice
  • DIETARY_SUPPLEMENT Dietary Intervention
  • OTHER Message

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2020-02-10
Est. Completion 2023-08-01
Phase Phase 2

Sponsor

SWOG Cancer Research Network

270 total trials

What the Registry Record Tells You About NCT04205955

The ClinicalTrials.gov registry entry for NCT04205955 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.

NCT04205955 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04205955 about?

NCT04205955 is a clinical study titled "Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors". This phase II trial studies how a diet intervention works in improving bowel dysfunction symptoms related in colon or rectal cancer survivors. Changing a diet may be helpful in reducing the severity of bowel symptoms, including diarrhea and constipation, and improve quality of life in colon or recta...

What is the current status of trial NCT04205955?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 95 participants. The study started on 2020-02-10. Estimated completion is 2023-08-01.

What interventions are being tested in trial NCT04205955?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Best Practice (OTHER), Dietary Intervention (DIETARY_SUPPLEMENT), Message (OTHER).

Who is sponsoring clinical trial NCT04205955?

This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.